vs
Bowhead Specialty Holdings Inc.（BOW）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Bowhead Specialty Holdings Inc.的1.3倍（$197.9M vs $151.7M），Bowhead Specialty Holdings Inc.净利率更高（9.8% vs 6.7%，领先3.1%），Bowhead Specialty Holdings Inc.自由现金流更多（$326.0M vs $17.6M）
Bowhead Specialty Holdings Inc.是一家专业保险控股企业，主营财产及意外伤害保险产品，聚焦北美地区服务不足的小众细分市场，为商业和个人客户提供定制化风险管理方案与专属保险保障服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BOW vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.3倍
$151.7M
净利率更高
BOW
高出3.1%
6.7%
自由现金流更多
BOW
多$308.5M
$17.6M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $197.9M |
| 净利润 | $14.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 11.7% | 9.0% |
| 净利率 | 9.8% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.44 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BOWRGEN
| Q4 25 | $151.7M | $197.9M | ||
| Q3 25 | $143.9M | $188.8M | ||
| Q2 25 | $133.3M | $182.4M | ||
| Q1 25 | $122.7M | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | $116.8M | $154.9M | ||
| Q2 24 | $98.9M | $154.1M | ||
| Q1 24 | — | $151.3M |
净利润BOWRGEN
| Q4 25 | $14.8M | $13.3M | ||
| Q3 25 | $15.2M | $14.9M | ||
| Q2 25 | $12.3M | $14.9M | ||
| Q1 25 | $11.4M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $12.1M | $-654.0K | ||
| Q2 24 | $5.5M | $3.3M | ||
| Q1 24 | — | $2.1M |
毛利率BOWRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率BOWRGEN
| Q4 25 | 11.7% | 9.0% | ||
| Q3 25 | 13.3% | 8.9% | ||
| Q2 25 | 11.9% | 7.6% | ||
| Q1 25 | 11.8% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | 13.5% | -5.1% | ||
| Q2 24 | 7.5% | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率BOWRGEN
| Q4 25 | 9.8% | 6.7% | ||
| Q3 25 | 10.5% | 7.9% | ||
| Q2 25 | 9.3% | 8.2% | ||
| Q1 25 | 9.3% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 10.4% | -0.4% | ||
| Q2 24 | 5.6% | 2.2% | ||
| Q1 24 | — | 1.4% |
每股收益（稀释后）BOWRGEN
| Q4 25 | $0.44 | $0.24 | ||
| Q3 25 | $0.45 | $0.26 | ||
| Q2 25 | $0.36 | $0.26 | ||
| Q1 25 | $0.34 | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | $0.36 | $-0.01 | ||
| Q2 24 | $0.20 | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $193.5M | $767.6M |
| 总债务越低越好 | $146.4M | $542.2M |
| 股东权益账面价值 | $448.3M | $2.1B |
| 总资产 | $2.4B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.33× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BOWRGEN
| Q4 25 | $193.5M | $767.6M | ||
| Q3 25 | $197.9M | $748.7M | ||
| Q2 25 | $114.8M | $708.9M | ||
| Q1 25 | $88.0M | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | $132.9M | $784.0M | ||
| Q2 24 | $180.3M | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务BOWRGEN
| Q4 25 | $146.4M | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BOWRGEN
| Q4 25 | $448.3M | $2.1B | ||
| Q3 25 | $430.2M | $2.1B | ||
| Q2 25 | $407.2M | $2.1B | ||
| Q1 25 | $391.0M | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | $364.7M | $2.0B | ||
| Q2 24 | $339.9M | $2.0B | ||
| Q1 24 | — | $2.0B |
总资产BOWRGEN
| Q4 25 | $2.4B | $2.9B | ||
| Q3 25 | $2.1B | $2.9B | ||
| Q2 25 | $1.9B | $2.9B | ||
| Q1 25 | $1.8B | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | — | $2.8B |
负债/权益比BOWRGEN
| Q4 25 | 0.33× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $331.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $326.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 214.9% | 8.9% |
| 资本支出强度资本支出/营收 | 3.7% | 4.1% |
| 现金转化率经营现金流/净利润 | 22.34× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $593.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BOWRGEN
| Q4 25 | $331.6M | $25.7M | ||
| Q3 25 | $114.7M | $48.1M | ||
| Q2 25 | $109.0M | $28.6M | ||
| Q1 25 | $47.7M | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | $119.4M | $49.3M | ||
| Q2 24 | — | $42.2M | ||
| Q1 24 | — | $44.7M |
自由现金流BOWRGEN
| Q4 25 | $326.0M | $17.6M | ||
| Q3 25 | $113.5M | $43.4M | ||
| Q2 25 | $107.4M | $21.5M | ||
| Q1 25 | $46.5M | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | $118.4M | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率BOWRGEN
| Q4 25 | 214.9% | 8.9% | ||
| Q3 25 | 78.8% | 23.0% | ||
| Q2 25 | 80.6% | 11.8% | ||
| Q1 25 | 37.9% | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | 101.4% | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度BOWRGEN
| Q4 25 | 3.7% | 4.1% | ||
| Q3 25 | 0.9% | 2.5% | ||
| Q2 25 | 1.2% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 0.9% | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率BOWRGEN
| Q4 25 | 22.34× | 1.93× | ||
| Q3 25 | 7.56× | 3.23× | ||
| Q2 25 | 8.83× | 1.92× | ||
| Q1 25 | 4.18× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.88× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
